The new world: hematopoietic stem cell transplant during a pandemic
Author:
- 26 August 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 28 (6) , 389-393
Abstract
Purpose of review: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted every facet of hematopoietic cell transplantation. This article reviews the adjustments to recipient and donor care that occurred in response to this unprecedented event. Recent findings: Transplant centers modified algorithms, patient flow, education, and how we provided care. Our donor center partners reworked how donors were evaluated and products delivered to the transplant center. Our professional societies provided guidelines for patient and donor care and rapidly modified these based upon the never-ending stream of new data learned about SARS-CoV-2. Our research organizations provided rapid analyses to ensure the care modifications necessitated did not have a profound negative impact on our patients or donors. Summary: The efforts of transplant providers and donor centers worldwide allowed patients to receive the transplant needed with assurances that they were receiving the best care available despite the worldwide challenge.Keywords
This publication has 21 references indexed in Scilit:
- Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies CommitteeTransplantation and Cellular Therapy, 2020
- Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy RecipientsTransplantation and Cellular Therapy, 2020
- Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant UnitFrontiers in Oncology, 2020
- Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be LearnedFrontiers in Oncology, 2020
- The clinical impact of COVID-19 epidemic in the hematologic settingAdvances in Biological Regulation, 2020
- Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic AnemiaTransplantation and Cellular Therapy, 2020
- Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best PracticesTransplantation and Cellular Therapy, 2020
- Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisTransplantation and Cellular Therapy, 2020
- The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyBone Marrow Transplantation, 2020
- Coronavirus Disease 2019: Coronaviruses and Blood SafetyTransfusion Medicine Reviews, 2020